From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications DOI Creative Commons
Timur Saliev, Prim B. Singh

Cells, Год журнала: 2024, Номер 13(24), С. 2052 - 2052

Опубликована: Дек. 12, 2024

Cellular rejuvenation therapies represent a transformative frontier in addressing age-related decline and extending human health span. By targeting fundamental hallmarks of aging—such as genomic instability, epigenetic alterations, mitochondrial dysfunction, cellular senescence—these aim to restore youthful functionality cells tissues, offering new hope for treating degenerative diseases. Recent advancements have showcased range strategies, including reprogramming, senolytic interventions, restoration, stem cell-based approaches, gene-editing technologies like CRISPR. Each modality has demonstrated substantial potential preclinical models is now being cautiously explored early-stage clinical trials. However, translating these from the laboratory practice presents unique challenges: safety concerns, delivery precision, complex regulatory requirements, ethical considerations, high costs impede widespread adoption. This review examines current landscape rejuvenation, highlighting key advancements, risks, strategies needed overcome hurdles.

Язык: Английский

Deep learning and generative artificial intelligence in aging research and healthy longevity medicine DOI Creative Commons
Dominika Wilczok

Aging, Год журнала: 2025, Номер unknown

Опубликована: Янв. 16, 2025

With the global population aging at an unprecedented rate, there is a need to extend healthy productive life span. This review examines how Deep Learning (DL) and Generative Artificial Intelligence (GenAI) are used in biomarker discovery, deep clock development, geroprotector identification generation of dual-purpose therapeutics targeting disease. The paper explores emergence multimodal, multitasking research systems highlighting promising future directions for GenAI human animal research, as well clinical application longevity medicine.

Язык: Английский

Процитировано

0

Unlocking Longevity in Aesthetic Dermatology: Epigenetics, Aging, and Personalized Care DOI Creative Commons
Diala Haykal, Frédéric Flament,

Pascale Mora

и другие.

International Journal of Dermatology, Год журнала: 2025, Номер unknown

Опубликована: Март 10, 2025

ABSTRACT The concept of aging has evolved from being primarily attributed to genetic factors recognizing the critical role epigenetic mechanisms. Recent advancements, such as clocks, have provided tools assess biological age and offer insights into processes at molecular level. In aesthetic dermatology, understanding these allows for more personalized, effective interventions targeting root causes skin aging. This review explores interplay changes, aging, potential personalized care enhance longevity rejuvenation. is based on an extensive literature search conducted across PubMed other scientific databases. Studies focused mechanisms DNA methylation, histone modifications, their relationship Particular attention was given recent advancements in including Horvath's Clock GrimAge, implications dermatological treatments. Epigenetic Clock, demonstrated utility assessing through methylation markers, revealing actionable processes. Energy‐based devices like fractional lasers radiofrequency shown promise reversing age‐related promoting collagen synthesis, reducing age. Additionally, lifestyle diet, sleep, circadian rhythm alignment significantly influence health. Integrating dermatology represents a paradigm shift rejuvenation, allowing treatments that address visible signs underlying Using clocks provides framework tailoring individual patient needs, optimizing outcomes, extending results. Future research should focus longitudinal studies, accessibility, ethical considerations fully harness epigenetics health overall well‐being.

Язык: Английский

Процитировано

0

The ongoing challenge of slowing aging through drug discovery DOI Creative Commons
David G. Le Couteur, Stuart L. Simpson, Victoria C. Cogger

и другие.

Expert Opinion on Drug Discovery, Год журнала: 2025, Номер unknown

Опубликована: Март 18, 2025

Язык: Английский

Процитировано

0

How to promote healthy aging across the life cycle DOI Creative Commons
Camilla Cocchi, Maria Beatrice Zazzara,

Elena Levati

и другие.

European Journal of Internal Medicine, Год журнала: 2025, Номер unknown

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

From biology of ageing to geroscience: where will knowledge take us? DOI
Aurélie Mailliez, Chantal Fradin, Éric Boulanger

и другие.

Age and Ageing, Год журнала: 2025, Номер 54(4)

Опубликована: Март 28, 2025

Abstract Healthy life expectancy is a major challenge in many countries and one of the World Health Organisation’s main concerns for current decade. With different animal models, from invertebrates to mammals, research into biology ageing has identified various biological physiological processes that alter quality ageing. Twelve characteristics have been defined, aim growing number studies find how slow down or halt their onset. Unfortunately, direct transposition models humans too often disappointing, race bring anti-ageing products market source misleading promises. The development geroscience will enable identification validation, with more relevant clinical evidence, pro-ageing targets develop therapies healthy

Язык: Английский

Процитировано

0

Mesenchymal stem cells and their derivatives as potential longevity-promoting tools DOI Creative Commons

Ekaterina Rudnitsky,

Alex Braiman,

Marina Wolfson

и другие.

Biogerontology, Год журнала: 2025, Номер 26(3)

Опубликована: Апрель 21, 2025

Abstract Mesenchymal stem cells (MSCs) and blood plasma/MSC-derived extracellular vesicles (EVs) offer promising tools to promote longevity treat age-related diseases. MSCs have low immunogenicity tumorigenicity, their efficacy is relatively independent of the donor age in humans (but not rodents). Systemic administration cell/blood-derived EVs modified omic profiles various organs aged rodents towards young ones. The application appears be even more beneficial than MSCs. Remarkably, over 70% microRNAs, which are over-presented ESC-derived EVs, were found target longevity-associated genes. Along with MSCs, other types reported display health- lifespan-extending effects. Pluripotent Muse cells, a specific subpopulation possess number unique features, could particularly relevant for promoting healthspan. rejuvenation potential warrants further investigation both animal models clinical trials, using aging clocks biological determination as one endpoints.

Язык: Английский

Процитировано

0

Perspectives of Regenerative Medicine in Dermatology and Cosmetology DOI Creative Commons
Enzo Berardesca, Norma Cameli

Cosmetics, Год журнала: 2024, Номер 11(6), С. 188 - 188

Опубликована: Окт. 30, 2024

Regenerative medicine has revolutionized the field of biological sciences, pharmacology and healthcare, bringing a new approach to treatments various health conditions. Dermatology aesthetic are interested in these scientific approaches as well. From this point view, many areas skin cosmetology may be involved, but several questions should answered before procedures become routine offices hospitals. Indeed scientific, ethical, financial issues still have addressed detail. Nevertheless, ongoing research technological advancements expected further improve therapies. The integration artificial intelligence machine learning could enhance precision regenerative treatments, making them more effective accessible forthcoming years.

Язык: Английский

Процитировано

1

From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications DOI Creative Commons
Timur Saliev, Prim B. Singh

Cells, Год журнала: 2024, Номер 13(24), С. 2052 - 2052

Опубликована: Дек. 12, 2024

Cellular rejuvenation therapies represent a transformative frontier in addressing age-related decline and extending human health span. By targeting fundamental hallmarks of aging—such as genomic instability, epigenetic alterations, mitochondrial dysfunction, cellular senescence—these aim to restore youthful functionality cells tissues, offering new hope for treating degenerative diseases. Recent advancements have showcased range strategies, including reprogramming, senolytic interventions, restoration, stem cell-based approaches, gene-editing technologies like CRISPR. Each modality has demonstrated substantial potential preclinical models is now being cautiously explored early-stage clinical trials. However, translating these from the laboratory practice presents unique challenges: safety concerns, delivery precision, complex regulatory requirements, ethical considerations, high costs impede widespread adoption. This review examines current landscape rejuvenation, highlighting key advancements, risks, strategies needed overcome hurdles.

Язык: Английский

Процитировано

1